Critic at Large

» public health and policy

Most Recent

image: Overspending on Overhead

Overspending on Overhead

By | February 1, 2015

Federal research dollars are needlessly wasted as scientists spend more and more of their time trying to recoup operational costs.

5 Comments

image: Psychiatry: An SOS Call

Psychiatry: An SOS Call

By | May 1, 2014

Social policies shaped the practice of psychiatry in the past. As the discipline becomes ever more scientific, the effects of social policy on patient well-being must not be ignored.

0 Comments

image: The Great Divide

The Great Divide

By | December 1, 2013

A two-way bridge between science and policy is desperately needed.

2 Comments

image: DIYbio: Low Risk, High Potential

DIYbio: Low Risk, High Potential

By | March 1, 2013

Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.

5 Comments

image: Regulating Amateurs

Regulating Amateurs

By | March 1, 2013

How should the government ensure the safety and responsibility of do-it-yourself biologists?

2 Comments

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Science and Democracy

Science and Democracy

By | October 1, 2012

Researchers and conscientious citizens must unite against the partisan rancor in American politics and restore the role of scientific information in policymaking.

1 Comment

image: One Year On

One Year On

By | March 1, 2012

Some thoughts about the ecological fallout from Fukushima

0 Comments

image: An Evolving Science for an Evolving Time

An Evolving Science for an Evolving Time

By | January 1, 2012

Twenty-first century challenges to the public health of all the world’s populations require forward-looking commitments from epidemiologists.

12 Comments

image: Hard and Harder

Hard and Harder

By | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

18 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech